Sato Junko, Nakajima Kenichi, Mita Tomoya, Koshibu Mami, Sato Ayako, Goto Hiromasa, Ikeda Fuki, Nishida Yuya, Aso Katsumi, Watada Hirotaka
Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Aso Clinic, 11-1 Tsutsui-cho, Numazu-shi, Shizuoka, 410-0041, Japan.
Diabetes Ther. 2024 Apr;15(4):883-892. doi: 10.1007/s13300-024-01539-0. Epub 2024 Feb 15.
Recent studies have shown that the quality of life (QOL) of people living with type 1 diabetes (T1D) is poor and must be improved. However, the living situation and QOL of adults living with T1D in Japan have not been fully clarified. This study will examine their lifestyle, QOL, and clinical situation, as well as the relationships between them.
This is a prospective, 5-year follow-up observational study. Between December 2019 and September 2021, we enrolled adults in Japan who were living with T1D and receiving insulin therapy, and are acquiring longitudinal clinical data and the responses to seven questionnaires regarding lifestyle and QOL. The primary study outcomes are (1) the relationship between Problem Areas in Diabetes (PAID) scores and various factors including demographic data, clinical characteristics, medical history, lifestyle habits, treatment history, biochemical data, and the scores of questionnaires; and (2) the relationship between Beck Depression Inventory (BDI)-II scores and various factors aforementioned. The secondary outcomes are the relationships between various factors aforementioned and each of the following: (1) blood glucose control, (2) blood lipid control, (3) dietary patterns, (4) fear of hypoglycemia, (5) sleep patterns, and (6) physical activity.
We registered 352 participants. The median age was 49 (41-63) years, and the median duration of T1D was 13 (8-20) years. All the results will be available in 2026. We expect to clarify the factors associated with decreased QOL, and that this knowledge will contribute to improving QOL in adults in Japan who are living with T1D and receiving insulin therapy.
Clinical Trials.gov identifier, UMIN000044088.
最近的研究表明,1型糖尿病(T1D)患者的生活质量(QOL)较差,必须加以改善。然而,日本成年T1D患者的生活状况和生活质量尚未得到充分阐明。本研究将考察他们的生活方式、生活质量和临床状况,以及它们之间的关系。
这是一项前瞻性、为期5年的随访观察性研究。在2019年12月至2021年9月期间,我们招募了日本成年T1D患者,他们正在接受胰岛素治疗,并收集纵向临床数据以及关于生活方式和生活质量的七份问卷的回复。主要研究结果包括:(1)糖尿病问题领域(PAID)评分与各种因素之间的关系,这些因素包括人口统计学数据、临床特征、病史、生活习惯、治疗史、生化数据和问卷评分;(2)贝克抑郁量表(BDI)-II评分与上述各种因素之间的关系。次要结果是上述各种因素与以下各项之间的关系:(1)血糖控制,(2)血脂控制,(3)饮食模式,(4)低血糖恐惧,(5)睡眠模式,以及(6)身体活动。
我们登记了352名参与者。中位年龄为49(41-63)岁,T1D的中位病程为13(8-20)年。所有结果将于2026年公布。我们期望阐明与生活质量下降相关的因素,并且这些知识将有助于改善日本接受胰岛素治疗的成年T1D患者的生活质量。
ClinicalTrials.gov标识符,UMIN000044088。